| [1] |
WHO Recommendations on interventions to improve preterm birth outcomes[M/OL]．Geneva: World Health Organization, 2015[2022-4-6].
URL
|
| [2] |
Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality. RCOG Green-top Guideline No.74 [J]．BJOG,129(8):e35-e60.
|
| [3] |
Mcgoldrick E, Stewart F, Parker R，et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth [J]．Cochrane Database Syst Rev，2020,12(12):1-220.
|
| [4] |
Gerten KA, Coonrod DV, Bay RC，et al.Cesarean delivery and respiratory distress syndrome: does labor make a difference？[J]. Am J Obstet Gynecol，2005,193(3 Pt2):1061-1064.
|
| [5] |
Vidic Z, Blickstein I, Stucin Gantar I，et al.Timing of elective cesarean section and neonatal morbidity: a population-based study[J]．J Matern Fetal Neonatal Med，2016,29(15):2461-2463.
|
| [6] |
Sotiriadis A, Mcgoldrick E, Makrydimas G，et al. Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes [J]．Cochrane Database Syst Rev，2021,12(12):Cd006614.
|
| [7] |
Gupta K, Rajagopal R, King F，et al. Complications of antenatal corticosteroids in infants born by early term scheduled cesarean section [J]．Diabetes Care，2020,43(4):906-908.
|
| [8] |
Stutchfield PR, Whitaker R, Gliddon AE，et al. Behavioural，educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)[J]．Arch Dis Child Fetal Neonatal Ed，2013,98(3):F195-200.
|
| [9] |
Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children [J]．JAMA, 2020, 323(19):1924-1933.
|
| [10] |
Shanks AL, Grasch JL, Quinney SK，et al.Controversies in antenatal corticosteroids [J]．Semin Fetal Neonatal Med，2019,24(3):182-188.
|
| [11] |
Deshmukh M, Patole S. Antenatal corticosteroids in impending preterm deliveries before 25 weeks′ gestation[J]．Arch Dis Child Fetal Neonatal Ed，2018,103(2):F173-176.
|
| [12] |
Mactier H, Bates SE, Johnston T，et al. Perinatal management of extreme preterm birth before 27 weeks of gestation：a framework for practice[J]．Arch Dis Child Fetal Neonatal Ed，2020,105(3): 232-239.
|
| [13] |
Gyamfi-Bannerman C, Thom EA, Blackwell SC，et al. Antenatal betamethasone for women at risk for late preterm delivery [J]．N Engl J Med，2016,374(14):1311-1320.
|
| [14] |
Viteri OA, Blackwell SC, Chauhan SP，et al.Antenatal corticosteroids for the prevention of respiratory distress syndrome in premature twins[J]．Obstet Gynecol，2016,128(3):583-591.
|
| [15] |
王竞雪，孙瑜. 产前糖皮质激素预防双胎妊娠新生儿呼吸窘迫综合征效果的研究进展 [J]. 中华围产医学杂志，2021,24(2):147-151.
|
| [16] |
Twin and triplet pregnancy. NICE Guideline, N0.137 [M/OL]. London: National Institue for Health and Care Excellence. 2019[2022-4-6].
URL
|
| [17] |
Jolley JA, Rajan PV, Petersen R，et al. Effect of antenatal betamethasone on blood glucose levels in women with and without diabetes[J]．Diabetes Res Clin Pract，2016,118:98-104.
|
| [18] |
Diabetes in pregnancy：management from preconception to the postnatal period [M/OL]．London：National Institute for Health and Care Excellence，2015[2022-4-6].
URL
|
| [19] |
Dashora U, Murphy HR, Temple RC，et al.Managing hyperglycaemia during antenatal steroid administration，labour and birth in pregnant women with diabetes[J]．Diabet Med，2018,35(8):1005-1010.
|
| [20] |
Paul R, Murugesh C, Chepulis L，et al.Should antenatal corticosteroids be considered in women with gestational diabetes before planned late gestation caesarean section[J]. Aust N Z J Obstet Gynaecol，2019,59(3):463-466.
|
| [21] |
Surveillance report (exceptional review) 2017–Preterm labour and birth (2015) NICE guideline NG25 [M/OL]. London: National Institute for Health and Care Excellence，2015[2022-4-6].
URL
|
| [22] |
Royal College of Obstetricians and Gynaecologists. Investigation and management of the small-for-gestational-age fetus. RCOG Green top Guideline no. 31. London：RCOG，2013：1-34.
|
| [23] |
Peaceman AM, Lai Y, Rouse DJ，et al. Length of latency with preterm premature rupture of membranes before 32 weeks′ gestation[J]．Am J Perinatol，2015,32(1):57-62.
|
| [24] |
Magann EF, Haram K, Ounpraseuth S，et al. Use of antenatal corticosteroids in special circumstances：a comprehensive review [J]．Acta Obstet Gynecol Scand，2017,96(4):395-409.
|
| [25] |
Gyamfi-Bannerman C, Son M. Preterm premature rupture of membranes and the rate of neonatal sepsis after two courses of antenatal corticosteroids [J]．Obstet Gynecol，2014,124(5):999-1003.
|
| [26] |
Brookfield KF, El-Sayed YY, Chao L，et al. Antenatal corticosteroids for preterm premature rupture of membranes：single or repeat course? [J]．Am J Perinatol，2015,32(6):537-544.
|
| [27] |
Kemp MW, Newnham JP, Challis JG，et al. The clinical use of corticosteroids in pregnancy [J]. Hum Reprod Update，2016,22(2):240-259.
|
| [28] |
Brownfoot FC, Gagliardi DI, Bain E，et al. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth [J]. Cochrane Database Syst Rev，2013,29(8):1-94.
|
| [29] |
Crowther CA, Ashwood P, Andersen CC，et al. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID)：a multicentre，double-blind，randomised controlled trial [J]. Lancet Child Adolesc Health，2019,3(11): 769-780.
|
| [30] |
Utama DP, Crowther CA. Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth [J]．Cochrane Database Syst Rev，2018,6(6):1-17.
|
| [31] |
武建利，朱启英. 早产产前糖皮质激素的使用[J]. 中国实用妇科与产科杂志，2018,34(2):158-160.
|
| [32] |
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth [J]. Cochrane Database Syst Rev，2006,3(3):1-273.
|
| [33] |
Norman M, Piedvache A, Børch K，et al. Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants：results from the EPICE cohort [J]．JAMA Pediatr，2017,171(7):678-686.
|
| [34] |
罗欣，漆洪波. 早产的诊治现状和面临的问题 [J]. 中国实用妇科与产科杂志，2020,36(2):111-114.
|
| [35] |
Battarbee AN, Ros ST, Esplin MS，et al. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes [J]．Am J Obstet Gynecol MFM，2020,2(1):1-7.
|
| [36] |
Itoh A, Saisho Y, Miyakoshi K，et al.Time-dependent changes in insulin requirement for maternal glycemic control during antenatal corticosteroid therapy in women with gestational diabetes：a retrospective study [J]．Endocr J, 2016, 63(1):101-104.
|
| [37] |
Di Pasquo E, Saccone G, Angeli L，et al.Determinants of neonatal hypoglycemia after antenatal administration of corticosteroids (ACS) for lung maturation：data from two referral centers and review of the literature[J]．Early Hum Dev，2020,143:104984.
|
| [38] |
Mckinlay CJD, Alsweiler JM, Anstice NS，et al.Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years[J]．JAMA Pediatr，2017,171(10):972-983.
|
| [39] |
Crowther CA, Middleton PF, Voysey M，et al.Effects of repeat prenatal corticosteroids given to women at risk of preterm birth：an individual participant data meta-analysis[J]．PLoS Med, 2019,16(4):e1002771.
|